AstraZeneca Vaccine Less Effective Against South African Variant

AstraZeneca Vaccine Less Effective Against South African Variant

British drugmaker AstraZeneca said on Saturday that its vaccine candidate being developed in partnership with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19.
South African COVID-19 Variant Detected in U.S. for First Time

South African COVID-19 Variant Detected in U.S. for First Time

Health officials announced on Thursday that the new South African COVID-19 variant had been detected in two people in South Carolina.
Real Time Analytics